Between new genetic discoveries and large randomized trials - Neurological research in the era of systems medicine

Thomas Misgeld; Stefan F. Lichtenthaler; Martin Dichgans

doi:10.1038/embor.2013.70

Between new genetic discoveries and large randomized trials - Neurological research in the era of systems medicine

Thomas Misgeld, Stefan F. Lichtenthaler, Martin Dichgans

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The 2012 Eibsee meeting on 'Cellular Mechanisms of Neurodegeneration' addressed the need to integrate research on classical neurodegenerative mechanisms with investigations that relate to the immunological, glial and vascular sequels that accompany and often propagate neuronal injury. We report on the central topics that were addressed and discuss future directions towards establishing 'systems neurology' as a new integrated research field.

Original language	English
Pages (from-to)	489-492
Number of pages	4
Journal	EMBO Reports
Volume	14
Issue number	6
DOIs	https://doi.org/10.1038/embor.2013.70
State	Published - Jun 2013

Access to Document

10.1038/embor.2013.70

Cite this

@article{5ddc9318557c4e0099074185d88b8004,

title = "Between new genetic discoveries and large randomized trials - Neurological research in the era of systems medicine",

abstract = "The 2012 Eibsee meeting on 'Cellular Mechanisms of Neurodegeneration' addressed the need to integrate research on classical neurodegenerative mechanisms with investigations that relate to the immunological, glial and vascular sequels that accompany and often propagate neuronal injury. We report on the central topics that were addressed and discuss future directions towards establishing 'systems neurology' as a new integrated research field.",

author = "Thomas Misgeld and Lichtenthaler, {Stefan F.} and Martin Dichgans",

year = "2013",

month = jun,

doi = "10.1038/embor.2013.70",

language = "English",

volume = "14",

pages = "489--492",

journal = "EMBO Reports",

issn = "1469-221X",

publisher = "EMBO Press",

number = "6",

}

TY - JOUR

T1 - Between new genetic discoveries and large randomized trials - Neurological research in the era of systems medicine

AU - Misgeld, Thomas

AU - Lichtenthaler, Stefan F.

AU - Dichgans, Martin

PY - 2013/6

Y1 - 2013/6

N2 - The 2012 Eibsee meeting on 'Cellular Mechanisms of Neurodegeneration' addressed the need to integrate research on classical neurodegenerative mechanisms with investigations that relate to the immunological, glial and vascular sequels that accompany and often propagate neuronal injury. We report on the central topics that were addressed and discuss future directions towards establishing 'systems neurology' as a new integrated research field.

AB - The 2012 Eibsee meeting on 'Cellular Mechanisms of Neurodegeneration' addressed the need to integrate research on classical neurodegenerative mechanisms with investigations that relate to the immunological, glial and vascular sequels that accompany and often propagate neuronal injury. We report on the central topics that were addressed and discuss future directions towards establishing 'systems neurology' as a new integrated research field.

UR - http://www.scopus.com/inward/record.url?scp=84878542534&partnerID=8YFLogxK

U2 - 10.1038/embor.2013.70

DO - 10.1038/embor.2013.70

M3 - Article

C2 - 23670197

AN - SCOPUS:84878542534

SN - 1469-221X

VL - 14

SP - 489

EP - 492

JO - EMBO Reports

JF - EMBO Reports

IS - 6

ER -

Between new genetic discoveries and large randomized trials - Neurological research in the era of systems medicine

Abstract

Access to Document

Other files and links

Fingerprint

Cite this